NeuroPace, Inc. Share Price & Technical Analysis
NPCE · $16.92 (+3.93%)
Healthcare / Medical Devices
$16.92
+3.93%
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable an…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
1% return in May, -15% avg return in past 3 year May month.
13% return in 2026, 165% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -3% | -3% | -8% | 27% | 1% | – | – | – | – | – | – | – | 13% |
| 25 | 21% | -5% | -5% | -4% | 13% | -15% | -23% | 8% | 16% | -5% | 66% | -4% | 62% |
| 24 | 46% | 11% | -19% | -3% | -47% | 10% | 1% | 3% | -11% | -4% | 63% | 3% | 53% |
| 23 | 236% | 9% | -8% | 11% | -12% | 2% | -5% | 124% | 2% | -24% | 30% | 16% | 382% |
| 22 | -20% | -4% | 6% | -2% | -23% | -22% | 18% | -26% | -7% | -21% | -45% | -6% | -153% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Uptrend
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$535.06M
P/E ratio
—
52W high
$19.60
52W low
$7.56
Volume
1,72,579
Beta
1.93
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is NeuroPace, Inc. share price today?
- NeuroPace, Inc. (NPCE) last traded around $16.92 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NPCE have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NPCE. Download the app for real-time alerts.
- How can I analyze NeuroPace, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.